EarningsQ2 2023 Earnings Report

Circassia Pharmaceuticals (CSSPF) Q2 2023 Earnings Report

9 Followers

CSSPF Q2 2023 EPS Results

Actual EPS<$0.01

Consensus EPS―

Beat/Miss―

One Year Ago EPS$0.03

Actual Revenue$25.35M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+21.29%

QuarterQ2 2023

Date09/26/2023

TimeBefore Open

Conference CallTuesday, September 26, 2023

CSSPF Upcoming Earnings

Circassia Pharmaceuticals's next earnings date is estimated for March 23, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 23, 2027	2026 (Q4)	- / -	0.004	―
Sep 10, 2026	2026 (Q2)	- / -	0.019	―
Mar 24, 2026	2025 (Q4)	- / <0.01	-0.003	250.00% (<+0.01)
Sep 30, 2025	2025 (Q2)	- / 0.02	0.013	40.00% (<+0.01)
Apr 01, 2025	2024 (Q4)	- / >-0.01	0.023	-111.76% (-0.03)
Sep 24, 2024	2024 (Q2)	- / 0.01	0.008	66.67% (<+0.01)
Mar 26, 2024	2023 (Q4)	- / 0.02	0.022	6.25% (<+0.01)
Sep 26, 2023	2023 (Q2)	- / <0.01	0.028	-71.43% (-0.02)
Mar 21, 2023	2022 (Q4)	- / 0.02	0.015	45.45% (<+0.01)
Sep 14, 2022	2022 (Q2)	- / 0.03	0	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed